Specifically, a significant 2-fold increase in expression was observed in several genes in the MAPK signaling pathway in HNSCC relative to NCMT, including p38β, ERK2 and JNK2. This evidence concerns the gene MAPK1 and head and neck squamous cell carcinoma.